Zunhua Yang

965 total citations
58 papers, 762 citations indexed

About

Zunhua Yang is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zunhua Yang has authored 58 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 22 papers in Organic Chemistry and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zunhua Yang's work include Cancer therapeutics and mechanisms (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Diabetes Treatment and Management (8 papers). Zunhua Yang is often cited by papers focused on Cancer therapeutics and mechanisms (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Diabetes Treatment and Management (8 papers). Zunhua Yang collaborates with scholars based in China, South Korea and United States. Zunhua Yang's co-authors include Yuanying Fang, Pengwu Zheng, Shan Xu, Yi Jin, Wufu Zhu, Wufu Zhu, Sai‐Sai Xie, Haeil Park, Xin Sun and Zhihui Zhou and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Molecules.

In The Last Decade

Zunhua Yang

54 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zunhua Yang China 17 368 348 121 105 98 58 762
Jiquan Zhang China 17 410 1.1× 371 1.1× 118 1.0× 65 0.6× 48 0.5× 72 952
Xuewei Wu China 15 693 1.9× 463 1.3× 127 1.0× 212 2.0× 70 0.7× 28 1.3k
Qianbin Li China 18 467 1.3× 295 0.8× 31 0.3× 157 1.5× 135 1.4× 66 886
Kashif Haider India 14 246 0.7× 334 1.0× 52 0.4× 74 0.7× 39 0.4× 23 643
Linxiang Zhao China 21 631 1.7× 722 2.1× 99 0.8× 181 1.7× 46 0.5× 83 1.3k
Hanan S. Anbar Egypt 16 272 0.7× 224 0.6× 47 0.4× 105 1.0× 33 0.3× 45 605
Yuanying Fang China 16 285 0.8× 234 0.7× 159 1.3× 72 0.7× 16 0.2× 54 663
Maocai Yan China 19 493 1.3× 184 0.5× 123 1.0× 166 1.6× 25 0.3× 57 852
Ola I. A. Salem Egypt 14 217 0.6× 418 1.2× 62 0.5× 76 0.7× 35 0.4× 26 586
Kevin N. Dack United Kingdom 12 260 0.7× 221 0.6× 114 0.9× 99 0.9× 29 0.3× 22 683

Countries citing papers authored by Zunhua Yang

Since Specialization
Citations

This map shows the geographic impact of Zunhua Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zunhua Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zunhua Yang more than expected).

Fields of papers citing papers by Zunhua Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zunhua Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zunhua Yang. The network helps show where Zunhua Yang may publish in the future.

Co-authorship network of co-authors of Zunhua Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zunhua Yang. A scholar is included among the top collaborators of Zunhua Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zunhua Yang. Zunhua Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Huilan, Zunhua Yang, Ziwei Zhang, et al.. (2025). Potential edaravone/benzocyclopentenone derivatives alleviate cerebral ischemia reperfusion injury as neuroprotective agents. Bioorganic Chemistry. 157. 108288–108288. 1 indexed citations
2.
3.
Yang, Fukang, Shu Shi, Huilan Li, et al.. (2025). Design, synthesis, and antidiabetic activities of 5-methoxypyrimidine derivatives targeting GPR119 and DPP-4. Bioorganic & Medicinal Chemistry. 129. 118318–118318.
4.
Yang, Zunhua, et al.. (2024). Research progress of PROTACs for neurodegenerative diseases therapy. Bioorganic Chemistry. 147. 107386–107386. 11 indexed citations
5.
Zhang, Ziwei, Pei Hu, Zunhua Yang, et al.. (2024). Synthesis and Neuroprotective Evaluation of Substituted Indanone/Benzofuranone and Piperidine Hybrids. ACS Chemical Neuroscience. 15(10). 2042–2057. 3 indexed citations
6.
7.
He, Jie, Zhihui Zhou, Xin Sun, et al.. (2020). The new opportunities in medicinal chemistry of fourth-generation EGFR inhibitors to overcome C797S mutation. European Journal of Medicinal Chemistry. 210. 112995–112995. 57 indexed citations
8.
McGuire, Timothy R., Donald W. Coulter, Dachang Bai, et al.. (2019). Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus. BMC Cancer. 19(1). 837–837. 11 indexed citations
9.
Fang, Yuanying, Lijuan Xiong, Jianguo Hu, et al.. (2019). Synthesis and evaluation of novel fused pyrimidine derivatives as GPR119 agonists. Bioorganic Chemistry. 86. 103–111. 9 indexed citations
10.
Bernatchez, Jean, Zunhua Yang, Jerry Li, et al.. (2018). Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus. Antimicrobial Agents and Chemotherapy. 62(10). 21 indexed citations
11.
Liu, Jing, Jinshuai Lan, Yongbing Sun, et al.. (2018). Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation. Bioorganic Chemistry. 81. 512–528. 88 indexed citations
12.
Zhao, Bing, Fei Lei, Zunhua Yang, et al.. (2018). Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors. Molecules. 23(7). 1553–1553. 11 indexed citations
13.
Yang, Zunhua, Yuanying Fang, & Haeil Park. (2017). Synthesis and biological evaluation of pyrimidine derivatives with diverse azabicyclic ether/amine as novel GPR119 agonist. Bioorganic & Medicinal Chemistry Letters. 27(11). 2515–2519. 14 indexed citations
14.
Fang, Yuanying, Rikang Wang, Mingzhen He, et al.. (2016). Nitric oxide-donating derivatives of hederacolchiside A1: Synthesis and biological evaluation in vitro and in vivo as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 27(1). 98–101. 16 indexed citations
15.
Fang, Yuanying, et al.. (2016). Novel 5-nitropyrimidine derivatives bearing endo-azabicyclic alcohols/amines as potent GPR119 agonists. Bioorganic & Medicinal Chemistry. 25(1). 254–260. 13 indexed citations
16.
Wang, Linbo, et al.. (2014). Fucoxanthin induces growth arrest and apoptosis in human bladder cancer T24 cells by up-regulation of p21 and down-regulation of mortalin. Acta Biochimica et Biophysica Sinica. 46(10). 877–884. 44 indexed citations
17.
18.
Yang, Zunhua, Yuanying Fang, Tuan-Anh Nguyen Pham, Jong‐Kook Lee, & Haeil Park. (2012). Synthesis and biological evaluation of 5-nitropyrimidine analogs with azabicyclic substituents as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 23(5). 1519–1521. 20 indexed citations
19.
Pham, Tuan-Anh Nguyen, Zunhua Yang, Yuanying Fang, et al.. (2012). Synthesis and biological evaluation of novel 2,4-disubstituted quinazoline analogues as GPR119 agonists. Bioorganic & Medicinal Chemistry. 21(5). 1349–1356. 17 indexed citations
20.
Yang, Zunhua, Ji Yeon Lee, Tae Hyung Kim, et al.. (2011). Design, synthesis and anticancer activity of novel dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivatives. Bioorganic & Medicinal Chemistry Letters. 21(19). 5730–5734. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiquan Zhang Breakdown of academic impact, for papers by Xuewei Wu Breakdown of academic impact, for papers by Qianbin Li Breakdown of academic impact, for papers by Kashif Haider Breakdown of academic impact, for papers by Linxiang Zhao Breakdown of academic impact, for papers by Hanan S. Anbar Breakdown of academic impact, for papers by Yuanying Fang Breakdown of academic impact, for papers by Maocai Yan Breakdown of academic impact, for papers by Ola I. A. Salem Breakdown of academic impact, for papers by Kevin N. Dack
Rankless by CCL
2026